galactosamine has been researched along with transforming growth factor beta in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirasaki, S; Koide, N; Nakamura, M; Shinji, T; Shiraha, H; Tsuji, T; Ujike, K | 1 |
Horikawa, T; Nakazato, H; Oku, H; Suzuki, R; Tsuruta, Y | 1 |
Chen, CW; Fan, Z; Jia, Y; Lu, L; Mao, Y; Peng, YS; Song, Y; Yang, W; Zeng, M; Zhu, HY | 1 |
Chen, DF; Du, SH; Li, H; Li, Y; Liao, X; Wei, Z; Xu, ZW | 1 |
Asha, VV; Suresh, V | 1 |
Farooqi, H; Ganai, AA; Ganaie, IA; Verma, N | 1 |
Ganai, AA; Husain, M | 1 |
7 other study(ies) available for galactosamine and transforming growth factor beta
Article | Year |
---|---|
Kinetics of expression of connective tissue growth factor gene during liver regeneration after partial hepatectomy and D-galactosamine-induced liver injury in rats.
Topics: Animals; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Extracellular Matrix; Galactosamine; Growth Substances; Immediate-Early Proteins; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kinetics; Liver; Plasmids; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Regeneration; Ribonucleases; RNA; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Galactosamine; Interferon-gamma; Interleukin-10; Interleukin-12; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred C57BL; Necrosis; Pyridones; Shock, Septic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2002 |
[Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis].
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Calcium Hydroxide; Chemoprevention; Disease Models, Animal; Galactosamine; Liver Cirrhosis; Liver Function Tests; Male; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Transforming Growth Factor beta | 2002 |
[Effect of niupo zhibao pellet on transforming growth factor-beta1 and its receptor's expression in endotoxic shock rats with lung injury].
Topics: Animals; Drugs, Chinese Herbal; Female; Galactosamine; Lipopolysaccharides; Male; Rats; Rats, Sprague-Dawley; Receptors, Transforming Growth Factor beta; Respiratory Distress Syndrome; Shock, Septic; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Preventive effect of ethanol extract of Phyllanthus rheedii Wight. on D-galactosamine induced hepatic damage in Wistar rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Ethanol; Female; Galactosamine; Gene Expression Regulation; Liver; Liver Diseases; Male; Phyllanthus; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage.
Topics: Actins; Animals; Body Weight; Carnitine; Chronic Disease; Collagen Type I; Galactosamine; Gene Expression Regulation; Glycine; Hydroxyproline; In Situ Nick-End Labeling; Interleukin-6; Liver; Liver Cirrhosis; Male; Oxidative Stress; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine | 2016 |
Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways.
Topics: Animals; Blotting, Western; Chronic Disease; Collagen; Galactosamine; Genistein; Hepatic Stellate Cells; In Situ Nick-End Labeling; Liver; Liver Cirrhosis; Male; Rats, Wistar; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Tyrosine | 2017 |